Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Repligen Corporation - Common Stock
(NQ:
RGEN
)
145.54
-0.24 (-0.16%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Repligen Corporation - Common Stock
< Previous
1
2
3
4
5
6
Next >
Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth
November 12, 2024
Repligen Q3 earnings beat expectations with $0.43 EPS and $154.87 million in sales. The company raises 2024 EPS guidance and reports strong growth in CDMO and equipment.
Via
Benzinga
Topics
Earnings
Exposures
Financial
10 Health Care Stocks Whale Activity In Today's Session
November 12, 2024
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Evaluating Repligen: Insights From 6 Financial Analysts
September 26, 2024
Via
Benzinga
Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday?
August 16, 2024
Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York.
Via
Benzinga
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
July 31, 2024
Via
Benzinga
Repligen Corp. (NASDAQ: RGEN) Making Surprising Moves in Tuesday Session
April 23, 2024
Via
Investor Brand Network
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio?
August 04, 2024
Seven mid-cap stocks that performed well last week: LUMN, SHAK, PSN, CWAN, RGEN, FTDR, and NEO. Check if they're in your portfolio!
Via
Benzinga
Here's Why Shares in This Hot Healthcare Stock Surged This Week
August 02, 2024
The bioprocessing market is preparing for a recovery.
Via
The Motley Fool
Repligen Lowers Guidance On China Weakness, Analyst Expects
July 30, 2024
Repligen reports Q2 sales of $154.1 million, closely matching the consensus estimate. Adjusted gross margin fell to 49.6% from 50.2%, with an EPS of $0.33. CEO Tony J. Hunt highlights strong Pharma...
Via
Benzinga
PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
July 30, 2024
Via
Benzinga
Analyst Ratings For Repligen
December 20, 2023
Via
Benzinga
The Latest Analyst Ratings for Repligen
December 04, 2023
Via
Benzinga
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
June 26, 2024
Via
Benzinga
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
June 26, 2024
Via
Benzinga
Analyst Expectations for Repligen's Future
November 02, 2023
Via
Benzinga
Keybanc Maintains Overweight Rating for Repligen: Here's What You Need To Know
November 01, 2023
Via
Benzinga
Top 3 Health Care Stocks That Could Blast Off In June
June 21, 2024
Via
Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 13, 2024
Via
Benzinga
RGEN Stock Earnings: Repligen Misses EPS, Beats Revenue for Q1 2024
May 01, 2024
RGEN stock results show that Repligen missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
April 23, 2024
Via
Benzinga
Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
March 25, 2024
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Life Science-Focused Repligen Stock Today?
February 21, 2024
Repligen posts Q4 2023 results. CEO Tony Hunt highlights order strength in Filtration and Analytics. Positive momentum in new modalities; 2024 revenue forecast: $620-$650 million.
Via
Benzinga
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
January 26, 2024
U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
How Good Is Your Market Cap Knowledge?
January 11, 2024
A company with a $50 price per share might have a million shares outstanding or a billion shares outstanding. And unless you know, you don't know the price tag of the stock you're about to buy.
Via
The Motley Fool
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 26, 2024
Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.
Via
Benzinga
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
November 03, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
A New Bull Market Is Coming! 3 Stocks Set to Soar 65% to 132% Higher
November 01, 2023
Wall Street has high hopes for these stocks to buy for the next bull market. Consider adding them to your portfolio.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.